A detailed history of Barrow Hanley Mewhinney & Strauss LLC transactions in Becton Dickinson & CO stock. As of the latest transaction made, Barrow Hanley Mewhinney & Strauss LLC holds 5,391 shares of BDX stock, worth $1.23 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5,391
Previous 5,391 -0.0%
Holding current value
$1.23 Million
Previous $1.26 Million 3.18%
% of portfolio
0.0%
Previous 0.0%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$233.45 - $247.73 $57,195 - $60,693
245 Added 4.76%
5,391 $1.33 Million
Q3 2023

Nov 13, 2023

SELL
$254.9 - $283.59 $28.6 Million - $31.8 Million
-112,295 Reduced 95.62%
5,146 $1.33 Million
Q2 2023

Aug 10, 2023

SELL
$238.39 - $265.32 $3.09 Million - $3.44 Million
-12,971 Reduced 9.95%
117,441 $31 Million
Q1 2023

May 11, 2023

SELL
$229.71 - $259.35 $9.24 Million - $10.4 Million
-40,242 Reduced 23.58%
130,412 $32.3 Million
Q4 2022

Feb 14, 2023

SELL
$218.29 - $256.91 $255,181 - $300,327
-1,169 Reduced 0.68%
170,654 $43.4 Million
Q3 2022

Nov 10, 2022

BUY
$51.03 - $264.23 $127,319 - $659,253
2,495 Added 1.47%
171,823 $38.3 Million
Q2 2022

Aug 11, 2022

SELL
$234.74 - $275.42 $9,624 - $11,292
-41 Reduced 0.02%
169,328 $41.7 Million
Q1 2022

May 13, 2022

SELL
$243.64 - $270.48 $1.2 Million - $1.33 Million
-4,912 Reduced 2.82%
169,369 $45.1 Million
Q4 2021

Feb 10, 2022

BUY
$230.08 - $250.94 $8.76 Million - $9.56 Million
38,090 Added 27.97%
174,281 $43.8 Million
Q3 2021

Nov 12, 2021

SELL
$232.72 - $256.47 $8.13 Million - $8.96 Million
-34,921 Reduced 20.41%
136,191 $33.5 Million
Q2 2021

Aug 12, 2021

BUY
$232.65 - $254.58 $39.8 Million - $43.6 Million
171,112 New
171,112 $41.6 Million

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $65.1B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Barrow Hanley Mewhinney & Strauss LLC Portfolio

Follow Barrow Hanley Mewhinney & Strauss LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barrow Hanley Mewhinney & Strauss LLC, based on Form 13F filings with the SEC.

News

Stay updated on Barrow Hanley Mewhinney & Strauss LLC with notifications on news.